Literature DB >> 34147204

Use of molecular docking computational tools in drug discovery.

Francesca Stanzione1, Ilenia Giangreco2, Jason C Cole2.   

Abstract

Molecular docking has become an important component of the drug discovery process. Since first being developed in the 1980s, advancements in the power of computer hardware and the increasing number of and ease of access to small molecule and protein structures have contributed to the development of improved methods, making docking more popular in both industrial and academic settings. Over the years, the modalities by which docking is used to assist the different tasks of drug discovery have changed. Although initially developed and used as a standalone method, docking is now mostly employed in combination with other computational approaches within integrated workflows. Despite its invaluable contribution to the drug discovery process, molecular docking is still far from perfect. In this chapter we will provide an introduction to molecular docking and to the different docking procedures with a focus on several considerations and protocols, including protonation states, active site waters and consensus, that can greatly improve the docking results.
Copyright © 2021 Elsevier B.V. All rights reserved.

Keywords:  Drug discovery; Homology modelling; Molecular interaction; Molecular target; Protein databases; Scoring functions; Small molecule databases; Structure-based drug design (SBDD); Virtual screening (VS)

Mesh:

Substances:

Year:  2021        PMID: 34147204     DOI: 10.1016/bs.pmch.2021.01.004

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


  8 in total

1.  Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Tianwen Yao; Qingliang Wang; Shisheng Han; Yan Lu; Yanqiu Xu; Yi Wang
Journal:  Biomed Res Int       Date:  2022-07-05       Impact factor: 3.246

2.  Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.

Authors:  Peng Liu; Bing Han; Yanxia Zhang; Xiaojuan Wang
Journal:  Comput Intell Neurosci       Date:  2022-05-18

3.  DeepMHADTA: Prediction of Drug-Target Binding Affinity Using Multi-Head Self-Attention and Convolutional Neural Network.

Authors:  Lei Deng; Yunyun Zeng; Hui Liu; Zixuan Liu; Xuejun Liu
Journal:  Curr Issues Mol Biol       Date:  2022-05-19       Impact factor: 2.976

4.  A combined application of molecular docking technology and indirect ELISA for the serodiagnosis of bovine tuberculosis.

Authors:  Shengnan Song; Qian Zhang; Hang Yang; Jia Guo; Mingguo Xu; Ningning Yang; Jihai Yi; Zhen Wang; Chuangfu Chen
Journal:  J Vet Sci       Date:  2022-05       Impact factor: 1.603

5.  Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.

Authors:  Paola Ruiz Puentes; Laura Rueda-Gensini; Natalia Valderrama; Isabela Hernández; Cristina González; Laura Daza; Carolina Muñoz-Camargo; Juan C Cruz; Pablo Arbeláez
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

6.  Screening of β1- and β2-Adrenergic Receptor Modulators through Advanced Pharmacoinformatics and Machine Learning Approaches.

Authors:  Md Ataul Islam; V P Subramanyam Rallabandi; Sameer Mohammed; Sridhar Srinivasan; Sathishkumar Natarajan; Dawood Babu Dudekula; Junhyung Park
Journal:  Int J Mol Sci       Date:  2021-10-17       Impact factor: 5.923

7.  Identification of promising nutraceuticals against filarial immune-modulatory proteins: insights from in silico and ex vivo studies.

Authors:  Vipin Kumar; Ayushi Mishra; Anchal Singh
Journal:  RSC Adv       Date:  2022-08-11       Impact factor: 4.036

8.  Exploring the mechanism of Buyang Huanwu Decoction in the treatment of spinal cord injury based on network pharmacology and molecular docking.

Authors:  Ying Wang; Haixu Chen; Junwei Wang; Xin Chen; Lan Chen
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.